Med Fusion is closing the gap towards hitting its $65.7 million goal, having brought in $61.2 million so far.
Med Fusion has sold equity to 30 unnamed investors at a minimum investment of $9,000, according to a regulatory filing.
The Lewisville, Texas-based company offers laboratory and clinical trial services to healthcare and pharmaceutical companies. Med Fusion is housed in a 130,000 square foot facility that it hopes to expand to 500,000 square feet, and the company employs about 200, according to its website.
Med Fusion in 2012 landed a 5-year contract naming it a Roche Molecular Center of Excellence.